The top ten global pharma companies by revenue will be different in 2021 than they are today. These companies are based on a combination of sales and market share,and the difference in their revenue per employee is significant. Pfizer,Roche,Abbvie,Johnson & Johnson,and Sanofi-Aventis are all listed. Read on to learn more about each company and their growth prospects. And don’t forget to subscribe to our free email newsletter!
,,,Pfizer
,,,While AbbVie was the best performing company in 2020,the entire list is still a mixed bag. Only two companies grew more than 10% in revenue. AbbVie gained almost half of its revenue without COVID-19 drugs,thanks to the success of Humira. Merck,meanwhile,saw a 17% increase in revenue from its Keytruda drug. Similarly,Amgen and Novartis each managed to gain 5% or more in revenue from 2020.
,,,As with the previous report,this year’s ranking is based on a combination of factors. First,company profile information is based on annual reports and press releases,as well as metrics related to the company’s core role in advancing health care. The ranking takes into account pharma/biopharmaceutical sales,but may also take into account sales of smaller divisions. In addition,we have excluded the sales of large medical device,diagnostic,and consumer care businesses.
,,,The biggest news for Pfizer this year is that it broke its own record in 2021. Revenue for the top ten Big Pharma companies grew 19.8% in 2021. The company pulled ahead of its rival Roche,and now looks set to break the USD 100 billion barrier by 2022. Abbvie,MSD,and Johnson & Johnson also posted double-digit growth,while GSK’s sales remained flat.
,,,Roche
,,,If you’re looking to be part of the top ten global pharmaceutical companies in 2021,Roche is the company to beat. The company recently agreed to purchase one-third of Novartis shares,which it held for over 20 years. In addition to the acquisition of Novartis,Roche’s portfolio includes Tecentriq,the first cancer immunotherapy to be approved for use in early-stage lung cancer. It also plans to rely on two newly approved products,Skyrizi and Rinvoq,for growth. Both companies expect each asset to generate sales above USD 7.5 billion by 2025.
,,,In Germany,Roche has been named a MINT-Minded Company for its commitment to fostering a culture of innovation and learning. MINT stands for Mathematics,Information Technology,Natural science and Technology. The “audimax MEDIEN GmbH” awards the MINT-Minded Company title to exceptional companies. The company supports education and research in these fields through its “MINT Zukunft schaffen” initiative.
,,,Abbvie
,,,In a recent report,we identified the 10 most valuable global pharmaceutical companies by market capitalization. Of these companies,Abbvie is one of the top five,but there are several other notable names that stand out as well. These companies have global reach and diverse business models. They employ a diverse mix of workers from all over the world,with a variety of industries and countries.
,,,The company’s recent results showed it is positioned for growth in 2020. The company is collaborating with Translate Bio on an mRNA vaccine and Biomedical Advanced Research and Development Authority on a self-testing solution. Its sales grew by 2.7% in 2019,and the company’s top-selling Humira drug continued to gain ground against biosimilar competition globally. AbbVie’s product portfolio rose by several billion dollars each in 2021,and the company expects further growth in 2022.
,,,AbbVie has also been a leader in revenue growth,and its latest report highlights the importance of establishing brand value and championing medical innovation. The COVID-19 pandemic has impacted many pharma companies,including Abbvie. However,its recent results are particularly impressive for a biotech company. Revenue growth grew by 23% for AbbVie,and 17% for Merck,which benefited from the sale of Keytruda. The other companies on the list only saw sales increases of five to ten percent.
,,,Johnson & Johnson
,,,There are pharma giants from all over the world,but some are more profitable than others. Johnson & Johnson,for instance,brought in nearly $83 billion in revenue in 2020,making it one of the top 10 revenue-producing companies in the world. It is a leading manufacturer of the COVID-19 vaccine in North America. It is one of the largest pharmaceutical companies in the world,and its market cap has increased significantly from just $125 billion in 2019 to $214.9 billion now. ultra men vitamins
,,,In addition to developing innovative drugs,J&J is investing heavily in research and development. During 2018,J&J spent 21% more than it did in 2020 on R&D. This increased R&D spending is a sign of the company’s advancement. In 2018,however,the company’s one-shot COVID vaccine hit a low point due to manufacturing problems and was eventually stopped.
,,,Novartis
,,,In a recent report,Pfizer said its revenue rose by 19.8% in 2021,breaking the previous record. The company has been growing rapidly,pulling away from rival Roche. It plans to hit USD 100 billion in sales in 2022. Other companies that posted double-digit growth in the rankings included AbbVie,MSD,Johnson & Johnson,and Novartis. The rest of the list stayed flat or declined slightly.
,,,The rankings are based on sales in pharma/biopharmaceutical categories and are based on the company’s annual report and press releases released throughout the year. Pharmaceutical and biopharmaceutical sales are the main factor,although results can also include animal health and smaller division sales. In recent years,pharmaceutical companies have separated their oncology and cancer businesses into separate groups. In addition,large pharmaceutical companies have excluded their diagnostics,consumer care,and medical device divisions.
,,,The end of 2019 saw the discovery of COVID-19,which has affected communities worldwide. Top pharmaceutical companies are rushing to develop a treatment for this disease. In addition,the COVID-19 pandemic is expected to affect communities around the world in 2020. Comirnaty has already become the fastest-selling drug in pharma history. In 2021,its sales will rise by more than US$36 billion.
,,,Bayer
,,,In terms of revenue and market value,Bayer is ranked fifth among global pharma companies. Its COVID vaccine has soared in sales,thanks in large part to the global crisis. This achievement reflects years of hard work and a willingness to pivot to the needs of patients. In terms of geographic presence,Bayer is represented by Switzerland,Germany,and the US. world class vitamins
,,,Novartis’ COVID vaccine,which protects against the COVID-19 virus,enjoyed great success outside of the U.S. Its Tagrisso drug,which is a targeted lung cancer therapy,generated more than $5 billion in sales in 2021. CEO Pascal Soriot has forecast much higher revenues for 2022 than the prior year,mainly due to its two new drugs.
,,,The company has also made significant investments in gene and cell therapies. It has spent five billion Euros on partnerships and new acquisitions and is exploring new therapeutic approaches in the field. These technologies hold the potential to transform modern therapeutics. Cell therapies are delivery of functional cells into a patient’s body. These can fight certain illnesses,such as cancer,or repair damaged cells. Gene therapy,on the other hand,targets genetic material to cure disease.
,,,Merck Merck Sharp & Dohme
,,,The company is a leading manufacturer of vaccines for the COVID-19 virus in North America,but it has slipped to third place. Recently,the company has regained momentum. Q2’2021 revenues were $19.0 billion,an increase of 86% over the same period in 2020. Eli Lilly is taking significant steps towards establishing itself as a global leader in the pharmaceutical industry. Its market cap in 2019 was $125 billion and has risen to a value of $214.9 billion in 2021.
,,,The company is headquartered in New Jersey and employs nearly 69,000 people around the world. Kenneth C. Frazier is the CEO of Merck and the company had $40.1 billion in revenue in 2017. It was founded in Darmstadt,Germany,in 1668. Friedrich Jacob Merck founded Angel Pharmacy,selling morphine and cocaine. In 1827,his son Heinrich Emanuel Merck took over and changed the company’s name to Merck. In 1891,the company expanded to the United States and was subsequently led by George Merck.
,,,Bristol Myers Squibb
,,,The New York City-based biopharmaceutical company produces prescription pharmaceuticals and biologics. Its top products include Orencia,anticoagulants,and cancer drugs. It has several research facilities around the world,including one in Cambridge,Massachusetts. It has ranked among the Top 10 Global Pharma Companies 2021. In 2018,Bristol-Myers Squibb had sales of $46.4 billion.
,,,The company boasts three of the top 10 best-selling drugs on the market. Although sales of Revlimid are expected to drop this year when the company’s patents lapse,Opdivo (nivolumab) will remain in the top 10. Its checkpoint inhibitor may catch up with Merck’s blockbuster,Opdivo. This could be good news for Bristol.
,,,AbbVie rose to the second spot in 2021,thanks to the continued success of Humira and its BTK inhibitor Imbruvica. The company is also boosted by the sales of Skyrizi,a drug approved for treating psoriasis. In 2020,the two drugs are expected to generate $2 billion in sales. It has high hopes for Skyrizi,which is a generic version of Humira,and Rinvoq,which is a biologic.
,